Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 4, 2005, Pages 956-964

  Feigenberg, Steven J ^a   Lee, W Robert ^b   Desilvio, Michelle L ^c   Winter, Kathryn ^c   Pisansky, Thomas M ^d   Bruner, Deborah Watkins ^a   Lawton, Colleen ^e   Morton, Gerald ^f   Baikadi, Madhava ^g   Sandler, Howard ^h  

^a FOX CHASE CANCER CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c AMERICAN COLLEGE OF RADIOLOGY   (United States)

^d MAYO CLINIC   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g Northeast Radiation Oncology Center   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Brachytherapy; Prostate Cancer; Quality of life

Indexed keywords

FUNCTIONAL ASSESSMENT; HEALTH CARE; RADIOTHERAPY; TUMORS;

FUNCTIONAL ASSESSMENT OF CANCER THERAPY-PROSTATE (FACT-P); HEALTH-RELATED QUALITY OF LIFE (HRQOL); INTERNATIONAL PROSTATE SYMPTOM SCORE (IPSS); PROSTATE BRACHYTHERAPY (PB); STANDARD ERROR OF THE MEAN (SEM);

ONCOLOGY;

ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERROR; FATIGUE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT OUTCOME; URINE INCONTINENCE;

AGED; BRACHYTHERAPY; HEALTH STATUS; HUMANS; IMPOTENCE; IODINE RADIOISOTOPES; KARNOFSKY PERFORMANCE STATUS; MALE; PENILE ERECTION; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; URINARY INCONTINENCE;

EID: 21244452660     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.12.061     Document Type: Article

References (37)

1. M.R. Cooperberg, D.P. Lubeck, M.V. Meng The changing face of low-risk prostate cancer trends in clinical presentation and primary management J Clin Oncol 22 2004 2141 2149
2. R. Hudson Brachytherapy treatments increasing among Medicare population. Health Policy Brief of the American Urologic Association 9 1999
3. A.V. D'Amico, N.J. Vogelzang Prostate brachytherapy increasing demand for the procedure despite the lack of standardized quality assurance and long term outcome data Cancer 86 1999 1632 1634
4. F. Joly, D. Brune, J.E. Couette Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer Ann Oncol 9 1998 751 757
5. J.M. Brandeis, M.S. Litwin, C.M. Burnison Quality of life outcomes after brachytherapy for early stage prostate cancer J Urol 163 2000 851 857
6. W.R. Lee, R.P. McQuellon, L.D. Case Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer J Urol 162 1999 403 406
7. P. Esper, F. Mo, G. Chodak Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument Urology 50 1997 920 928
8. M. Gray Psychometric evaluation of the international prostate symptom score Urol Nurs 18 1998 175 183
9. D.W. Bruner, C.B. Scott, D. McGowan The RTOG Modified Sexual Adjustment Questionnaire psychometric testing in the prostate cancer population [Abstract] Int J Radia Oncol Phys Biol 42 1998 202
10. D.F. Cella, D.S. Tulsky, G. Gray The functional assessment of cancer therapy scale development and validation of the general measure J Clin Oncol 11 1993 570 579
11. J.M.M. Waterhouse Development of the sexual adjustment questionnaire Oncol Nurs Forum 13 1986 53 59
12. W.R. Lee, R.P. McQuellon, K. Harris-Henderson A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer Int J Radiat Oncol Biol Phys 46 2000 77 81
13. W.R. Lee, R.P. McQuellon, D.L. McCullough A prospective analysis of patient-reported quality of life after prostate brachytherapy Semin Urol Oncol 18 2000 147 151
14. W.R. Lee, M.C. Hall, R.P. McQuellon A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy Int J Radiat Oncol Biol Phys 51 2001 614 623
15. S. Egawa, S. Shimura, A. Irie Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer Jpn J Clin Oncol 31 2001 541 547
16. J.W. Davis, D.A. Kuban, D.F. Lynch Quality of life after treatment for localized prostate cancer differences based on treatment modality J Urol 166 2001 947 952
17. J.T. Wei, R.L. Dunn, H.M. Sandler Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer J Clin Oncol 20 2002 557 566
18. T.M. Downs, N. Sadetsky, D.J. Pasta Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer - data from CaPSURE J Urol 170 2003 1822 1827
19. G.S. Merrick, W.M. Butler, K.E. Wallner Long-term urinary quality of life after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 56 2003 454 461
20. B. Movsas Quality of life in oncology trials a clinical guide Semin Radiat Oncol 13 2003 235 247
21. R. Gelber Quality of life assessment in clinical trials recent advances in clinical trial design and analysis 1995 Kluwer Academic Publishers Boston
22. P. Fayers Quality of life assessment, analysis and interpretation 2000 John Wiley & Sons, Ltd West Sussex, England
23. F. Roila, E. Cortesi Quality of life as a primary end point in oncology Ann Oncol 12 Suppl 3 2001 S3 S6
24. N.K. Aaronson, S. Ahmedzai, B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30 a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
25. K. Webster, D. Cella, K. Yost The Functional Assessment Of Chronic Illness Therapy (FACIT) measurement system properties, applications, and interpretation Health Qual Life Outcomes 1 2003 79
26. M.S. Litwin, R.D. Hays, A. Fink The UCLA Prostate Cancer Index development, reliability, and validity of a health-related quality of life measure Med Care 36 1998 1002 1012
27. C.G. Bacon, E. Giovannucci, M. Testa The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer J Urol 166 2001 1804 1810
28. A.R. Feinstein Clinical biostatistics. XLI. Hard science, soft data, and the challenges of choosing clinical variables in research Clin Pharmacol Ther 22 1977 485 498
29. D. Salsburg Hypothesis versus significance testing for controlled clinical trials a dialogue Stat Med 9 1990 201 211 discussion 213-204
30. M.A. Sprangers, C.M. Moinpour, T.J. Moynihan Assessing meaningful change in quality of life over time a users' guide for clinicians Mayo Clin Proc 77 2002 561 571
31. J. Ware Interpreting general health measures B. Spilker Quality of life and pharmacoeconomics in clinical trials 1996 Lippincott-Raven Philadelphia, PA 445 460
32. G.H. Guyatt, D. Osoba, A.W. Wu Methods to explain the clinical significance of health status measures Mayo Clin Proc 77 2002 371 383
33. K.W. Wyrwich, W.M. Tierney, F.D. Wolinsky Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life J Clin Epidemiol 52 1999 861 873
34. K.W. Wyrwich, N.A. Nienaber, W.M. Tierney Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life Med Care 37 1999 469 478
35. J. Cohen Analysis for the behavioral science 2nd ed. 1988 Lawrence Erlbaum Associates Hillsdale, NJ
36. J.T. Wei, R.L. Dunn, M.S. Litwin Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
37. L. Potters, T. Torre, P.A. Fearn Potency after permanent prostate brachytherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 50 2001 1235 1242